Xconomy’s Digital Events →
Healthline CEO West Shell
Sponsored · Whitepaper
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals